Wellington Management Group LLP Rocket Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 13,995,177 shares of RCKT stock, worth $147 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

13,995,177

Previous 11,242,144 24.49%

Holding current value

$147 Million

Previous $208 Million 15.28%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$11.35 - $18.82 $31.2 Million - $51.8 Million	2,753,033 Added 24.49%	13,995,177 $176 Million
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $36.7 Million - $54 Million	2,086,424 Added 22.79%	11,242,144 $208 Million
Q2 2024 Aug 13, 2024	SELL	$20.66 - $26.72 $7,830 - $10,126	-379 Reduced -0.0%	9,155,720 $197 Million
Q1 2024 May 15, 2024	BUY	$26.16 - $30.74 $240 Million - $281 Million	9,156,099 New	9,156,099 $247 Million
Q4 2023 Feb 12, 2024	BUY	$16.78 - $31.94 $138 Million - $262 Million	8,197,546 New	8,197,546 $246 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $43.4 Million - $69.3 Million	2,880,373 Added 56.01%	8,022,830 $164 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $17.2 Million - $24.4 Million	1,034,529 Added 25.18%	5,142,457 $102 Million
Q1 2023 May 12, 2023	BUY	$15.79 - $22.6 $9.49 Million - $13.6 Million	600,911 Added 17.13%	4,107,928 $70.4 Million
Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $443,377 - $651,049	28,605 Added 0.82%	3,507,017 $68.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $894,140 - $1.33 Million	72,283 Added 2.12%	3,478,412 $55.5 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $529,435 - $1.11 Million	-66,512 Reduced 1.92%	3,406,129 $46.9 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $240,012 - $431,875	-18,238 Reduced 0.52%	3,472,641 $55.1 Million
Q4 2021 Feb 11, 2022	BUY	$21.52 - $36.02 $3.11 Million - $5.21 Million	144,648 Added 4.32%	3,490,879 $76.2 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $23.9 Million - $42.7 Million	-871,744 Reduced 20.67%	3,346,231 $100 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $22 Million - $26.4 Million	558,898 Added 15.27%	4,217,975 $187 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $42.4 Million - $64.4 Million	977,556 Added 36.46%	3,659,077 $162 Million
Q4 2020 Feb 12, 2021	BUY	$23.3 - $59.57 $23.3 Million - $59.6 Million	999,916 Added 59.46%	2,681,521 $147 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $151,392 - $211,137	-7,385 Reduced 0.44%	1,681,605 $38.4 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $126,673 - $215,021	9,510 Added 0.57%	1,688,990 $35.4 Million
Q1 2020 May 14, 2020	SELL	$9.71 - $25.11 $836,662 - $2.16 Million	-86,165 Reduced 4.88%	1,679,480 $23.4 Million
Q4 2019 Feb 11, 2020	BUY	$11.07 - $24.23 $19.5 Million - $42.8 Million	1,765,645 New	1,765,645 $40.2 Million

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

108M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $792M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Rocket Pharmaceuticals, Inc. Transaction History